October 23, 2019
The anticonvulsant therapeutic class will not be reviewed at the Friday, Oct. 25 Drug Utilization Review Board meeting. HHSC will accept public testimony pertaining to anticonvulsants at the meeting, but the class will be reviewed at a future board meeting. The public will have additional opportunity to provide testimony when the class is reviewed at that time. Testimony from both Oct. and the later meeting will be considered by the DUR Board. For questions please email email@example.com.